COL1A1 and metabolic dysfunction-associated steatotic liver disease: Therefore, COL1A1 and COL1A2 are recognized as key molecular markers for MASLD fibrosis, and their expression levels can be used to assess hepatic fibrosis severity and predict therapeutic responses.41